MF
EDIT icon

Magnetar Financial’s Editas Medicine EDIT Stock Holding History

Magnetar Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$296K – 668
2020
Q2 		$296K Buy
+10,000
New +$261K 0.01% 340
2017
Q2 		– Sell
-11,982
Closed -$267K – 841
2017
Q1 		$267K Buy
+11,982
New +$248K ﹤0.01% 603

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Magnetar Financial's EDIT Position: Q3 2020 in Review

Magnetar Financial sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 10,000 shares — an estimated $296K sold.

Magnetar Financial first reported a position in EDIT in Q1 2017 and held it in 2 quarters. The position peaked at $296K in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • Magnetar Financial reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • Magnetar Financial sold 10,000 Editas Medicine shares in Q3 2020, an estimated $296K.
  • Magnetar Financial first reported a position in Editas Medicine in Q1 2017 and held it in 2 quarters.
  • Magnetar Financial's Editas Medicine position peaked at $296K in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Magnetar Financial's 13F filing for Q3 2020, filed 16 Nov 2020.